Relation between residual disease on day 19 and minimal residual disease (MRD) during clinical remission
| Residual disease on day 19 . | MRD at end of induction . | MRD during continuation therapy . | ||||||
|---|---|---|---|---|---|---|---|---|
| Week 14 . | Week 32 . | Week 56 . | ||||||
| ≥ 0.01% . | < 0.01% . | ≥ 0.01% . | < 0.01% . | ≥ 0.01% . | < 0.01% . | ≥ 0.01% . | < 0.01% . | |
| ≥ 0.01% | 27 | 26 | 14 | 35 | 1 | 40 | 3 | 40 |
| < 0.01% | 1 | 49 | 0 | 49 | 0 | 47 | 1 | 48 |
| Residual disease on day 19 . | MRD at end of induction . | MRD during continuation therapy . | ||||||
|---|---|---|---|---|---|---|---|---|
| Week 14 . | Week 32 . | Week 56 . | ||||||
| ≥ 0.01% . | < 0.01% . | ≥ 0.01% . | < 0.01% . | ≥ 0.01% . | < 0.01% . | ≥ 0.01% . | < 0.01% . | |
| ≥ 0.01% | 27 | 26 | 14 | 35 | 1 | 40 | 3 | 40 |
| < 0.01% | 1 | 49 | 0 | 49 | 0 | 47 | 1 | 48 |
MRD data were not available for all patients at all assessment times.